...
首页> 外文期刊>Evidence-based complementary and alternative medicine: eCAM >Efficacy of Ethanolic Extract of Syzygium aromaticum in the Treatment of Multidrug-Resistant Pseudomonas aeruginosa Clinical Isolates Associated with Urinary Tract Infections
【24h】

Efficacy of Ethanolic Extract of Syzygium aromaticum in the Treatment of Multidrug-Resistant Pseudomonas aeruginosa Clinical Isolates Associated with Urinary Tract Infections

机译:Syzygium aromaticum乙醇提取物在尿路感染相关的多药抗性铜绿假单胞菌临床分离物中的疗效

获取原文
           

摘要

Pseudomonas aeruginosa is an organism commonly found in the environment and one of the most common causes of human urinary tract infections in developed and developing countries. The present study aimed to investigate the effect of five medicinal plant extracts on the isolated drug-resistant P. aeruginosa clinical isolates. A total of 100 urine samples were collected from Nagaa Hammadi and Qena General Hospitals and private medical analysis laboratories in Qena governorate, Upper Egypt. Samples were screened for the prevalence of UTI pathogens by biochemical tests, antibiotics sensitivity, detection of virulence, and antibiotic-resistant genes by using multiplex PCR. P. aeruginosa is by far the subdominant causative agent with a percentage of 14%. Clinical isolates were multidrug-resistant, containing bla TEM , bla SHV , toxA , lasB , pslA , and fliC resistant and virulence genes. Based on bioactivity, the ethanolic extract of clove ( Syzygium aromaticum ) was the most active extract among tested medicinal plants and had the maximum zone of inhibition sized 23?mm against tested bacteria. The results of the minimum inhibitory concentration (MIC) and the minimum bactericidal concentration (MBC) showed a high decrease of inhibition within a concentration range of (10 to 121.25?mg/mL and 20 to 30?mg/mL, respectively). Further, major compounds of oleic acid (27.22%), guanosine (8.91%), indole (6.83%), 1-eicosene (6.30%), and cis-10-nonadecenoic acid (5.37%) were determined among 12 bioactive compounds in the ethanolic extract of S. aromaticum using gas chromatography-mass spectrometry (GC-MS). These results indicated that the ethanolic extract of S. aromaticum is a promising antibacterial agent for further studies aiming to control bacterial infections including MDR bacteria and develop novel therapeutic alternatives for the treatment of UTI.
机译:假单胞菌铜绿假单胞菌是在环境中常见的生物,以及发达国家和发展中国家的人类尿路感染最常见的原因之一。本研究旨在探讨五种药用植物提取物对分离药抗药性P.铜绿假单胞菌临床分离株的影响。从埃及QENA省,总共有100个尿液样本从Nagaa Hammadi和Qena General医院和私人医学分析实验室收集。通过使用多重PCR,通过生化试验,抗生素敏感性,毒力和抗生素抗性基因筛选uti病原体的普遍性的样品。 P.铜绿假单胞菌是迄今为止亚域的造成剂,百分比为14%。临床分离株是多药抗性,含有BLA TEM,BLA SHV,TOXA,LASB,PSLA和抗抗毒力基因。基于生物活性,丁香(Syzygium aromaticum)的乙醇提取物是测试的药用植物中最活跃的提取物,并具有抑制抑制尺寸的最大区23Ω·mm对抗测试的细菌。最小抑制浓度(MIC)和最小杀菌浓度(MBC)的结果表明,在(10至121.25×mg / ml和20至30×mg / ml的浓度范围内高降低抑制。此外,在12种生物活性化合物中测定,在12种生物活性化合物中测定主要化合物(27.22%),鸟苷(8.91%),鸟苷(8.91%),吲哚(6.83%),1-庚二烯(6.30%)和CIS-10-非二烯烃(5.37%)使用气相色谱 - 质谱(GC-MS)的S.芳香族乙醇提取物。这些结果表明,S.芳香族的乙醇提取物是一种有前途的抗菌剂,用于进一步研究,用于控制包括MDR细菌的细菌感染,并开发用于治疗UTI的新疗效替代品。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号